| Gene symbol | tk |
| GTO ID | GTC0003 |
| Trial ID | NCT00005025 |
| Disease | Ovarian Cancer |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | rv.HSV-TK |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | A Phase II Trial of In Vivo Gene Therapy With the Herpes Simplex Thymidine Kinase for the Treatment of Ovarian Cancer |
| Year | 2000 |
| Country | United States |
| Company sponsor | John Stoddard Cancer Center at Iowa Methodist Medical Center |
| Other ID(s) | CDR0000067546|HGTRI-0105|NCI-V00-1584 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||